RxDoctor Payments Data

India Hunt, APRN

Family · Marietta, GANPI 1134875404

Payments from drug & device makers

$662in general payments, 2019–2025

Across 15 payments — averaging $44.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bioventus LLC$237
  • KCI USA, Inc.$139
  • Si-bone, Inc.$125
  • Amgen$48
  • My01 Inc.$35
  • Vertex$32
  • plus $46 from 3 others

What the payments were for

  • Food & beverage$662100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bioventus LLC3$237
KCI USA, Inc.3$139
Si-bone, Inc.1$125
Amgen2$48
My01 Inc.2$35
Vertex1$32
Medtronic1$17
Biocomposites Inc1$15
Smith+Nephew1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$662 in reported general payments places this provider in the 60th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$32,447
Medicare patients
224
Services billed
726

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methocarbamol32$152
Meloxicam39$131
Tramadol Hcl31$107

Paid to pharmacies, not to this prescriber.

Other family in Marietta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →